220 related articles for article (PubMed ID: 35535740)
1. Isavuconazole therapeutic drug monitoring in critically ill ICU patients: A monocentric retrospective analysis.
Höhl R; Bertram R; Kinzig M; Haarmeyer GS; Baumgärtel M; Geise A; Muschner D; Prosch D; Reger M; Naumann HT; Ficker JH; Kubitz J; Steinmann J; Sörgel F
Mycoses; 2022 Jul; 65(7):747-752. PubMed ID: 35535740
[TBL] [Abstract][Full Text] [Related]
2. Clinical and demographic factors affecting trough levels of isavuconazole in critically ill patients with or without COVID-19.
Bertram R; Naumann HT; Bartsch V; Hitzl W; Kinzig M; Haarmeyer GS; Baumgärtel M; Geise A; Muschner D; Nentwich J; John S; Sörgel F; Steinmann J; Höhl R
Mycoses; 2023 Dec; 66(12):1071-1078. PubMed ID: 37700457
[TBL] [Abstract][Full Text] [Related]
3. Exposure-Response Relationships for Isavuconazole in Patients with Invasive Aspergillosis and Other Filamentous Fungi.
Desai AV; Kovanda LL; Hope WW; Andes D; Mouton JW; Kowalski DL; Townsend RW; Mujais S; Bonate PL
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923872
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of Intravenous Isavuconazole in Solid-Organ Transplant Recipients.
Wu X; Clancy CJ; Rivosecchi RM; Zhao W; Shields RK; Marini RV; Venkataramanan R; Nguyen MH
Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30275091
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic drug concentrations of isavuconazole following the administration of isavuconazonium sulfate capsules via gastro-jejunum tube: A case report.
Adamsick ML; Elshaboury RH; Gift T; Mansour MK; Kotton CN; Gandhi RG
Transpl Infect Dis; 2019 Apr; 21(2):e13048. PubMed ID: 30636363
[TBL] [Abstract][Full Text] [Related]
6. Influence of Sustained Low-Efficiency Dialysis Treatment on Isavuconazole Plasma Levels in Critically Ill Patients.
Lahmer T; Batres Baires G; Heilmaier M; Schmid RM; Sörgel F; Kinzig M; Huber W; Mayr U; Rasch S
Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31427296
[TBL] [Abstract][Full Text] [Related]
7. Variability and exposure-response relationships of isavuconazole plasma concentrations in the Phase 3 SECURE trial of patients with invasive mould diseases.
Kaindl T; Andes D; Engelhardt M; Saulay M; Larger P; Groll AH
J Antimicrob Chemother; 2019 Mar; 74(3):761-767. PubMed ID: 30476108
[TBL] [Abstract][Full Text] [Related]
8. Isavuconazole: A new broad-spectrum azole. Part 2: pharmacokinetics and clinical activity.
Ledoux MP; Denis J; Nivoix Y; Herbrecht R
J Mycol Med; 2018 Mar; 28(1):15-22. PubMed ID: 29551442
[TBL] [Abstract][Full Text] [Related]
9. Serial monitoring of isavuconazole blood levels during prolonged antifungal therapy.
Furfaro E; Signori A; Di Grazia C; Dominietto A; Raiola AM; Aquino S; Ghiggi C; Ghiso A; Ungaro R; Angelucci E; Viscoli C; Mikulska M
J Antimicrob Chemother; 2019 Aug; 74(8):2341-2346. PubMed ID: 31119272
[TBL] [Abstract][Full Text] [Related]
10. [Invasive aspergillosis in solid organ transplantation].
Silva JT; Torre-Cisneros J; Aguado JM
Rev Iberoam Micol; 2018; 35(4):206-209. PubMed ID: 30467000
[TBL] [Abstract][Full Text] [Related]
11. A simple high performance liquid chromatography-mass spectrometry method for Therapeutic Drug Monitoring of isavuconazole and four other antifungal drugs in human plasma samples.
Fatiguso G; Favata F; Zedda I; De Nicolò A; Cusato J; Avataneo V; Di Perri G; D'Avolio A
J Pharm Biomed Anal; 2017 Oct; 145():718-724. PubMed ID: 28806568
[TBL] [Abstract][Full Text] [Related]
12. Decreased isavuconazole trough concentrations in the treatment of invasive aspergillosis in an adult patient receiving extracorporeal membrane oxygenation support.
Miller M; Kludjian G; Mohrien K; Morita K
Am J Health Syst Pharm; 2022 Jul; 79(15):1245-1249. PubMed ID: 35377411
[TBL] [Abstract][Full Text] [Related]
13. Invasive mould infections in the ICU setting: complexities and solutions.
Bassetti M; Bouza E
J Antimicrob Chemother; 2017 Mar; 72(suppl_1):i39-i47. PubMed ID: 28355466
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness analysis of isavuconazole versus voriconazole for the treatment of patients with possible invasive aspergillosis in Sweden.
Floros L; Kuessner D; Posthumus J; Bagshaw E; Sjölin J
BMC Infect Dis; 2019 Feb; 19(1):134. PubMed ID: 30744563
[TBL] [Abstract][Full Text] [Related]
15. Isavuconazole use and TDM in real-world pediatric practice.
Fernández Ledesma B; Mendoza-Palomar N; Melendo Pérez S; Fernández-Polo A; Renedo Miró B; Pau Parra A; Luque Pardos S; Grau Cerrato S; Vima Bofarull J; Martín-Gómez MT; Pujol Jover M; Benítez-Carbante MI; Díaz de Heredia C; Soler-Palacin P
Antimicrob Agents Chemother; 2023 Dec; 67(12):e0082923. PubMed ID: 37962334
[TBL] [Abstract][Full Text] [Related]
16. Isavuconazole plasma concentrations in critically ill patients during extracorporeal membrane oxygenation.
Kriegl L; Hatzl S; Zurl C; Reisinger AC; Schilcher G; Eller P; Gringschl Y; Muhr T; Meinitzer A; Prattes J; Hoenigl M; Krause R
J Antimicrob Chemother; 2022 Aug; 77(9):2500-2505. PubMed ID: 35726095
[TBL] [Abstract][Full Text] [Related]
17. Isavuconazole Treatment of Invasive Fungal Sinusitis: A Post Hoc Analysis of the SECURE and VITAL Trials.
Durand ML; Kitt TM; Song Y; Marty FM
Clin Infect Dis; 2021 Sep; 73(6):e1380-e1383. PubMed ID: 33914864
[TBL] [Abstract][Full Text] [Related]
18. Impact of Mucositis on Absorption and Systemic Drug Exposure of Isavuconazole.
Kovanda LL; Marty FM; Maertens J; Desai AV; Lademacher C; Engelhardt M; Lu Q; Hope WW
Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28289034
[TBL] [Abstract][Full Text] [Related]
19. Validation of an Isavuconazole High-Performance Liquid Chromatography Assay in Plasma for Routine Therapeutic Drug Monitoring Applications.
Mueller SC; Karasch I; Lakner J; Wacke R
Ther Drug Monit; 2018 Aug; 40(4):503-506. PubMed ID: 29994987
[TBL] [Abstract][Full Text] [Related]
20. Refining the therapeutic range of posaconazole and isavuconazole for efficient therapeutic drug monitoring using a bioassay approach.
Willeman T; Tonini J; Garnaud C; Bailly S; Gandia P; Stanke-Labesque F; Maubon D; Gautier-Veyret E
Fundam Clin Pharmacol; 2020 Apr; 34(2):279-287. PubMed ID: 31505058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]